Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Induce Biologics is a regenerative medicine company focused on developing next-generation solutions for bone regeneration and repair. The company's proprietary Bio-Inductive Matrix (BIM) platform utilizes natural Bone Morphogenetic Proteins (nBMP) to replicate the body's complex natural healing signaling. Their technology is designed to provide a more effective and safer alternative to synthetic or recombinant bone graft substitutes by delivering a physiological blend of growth factors. Induce Biologics targets high-need applications in spinal fusion, orthopedic trauma, and oral/maxillofacial surgery. The company is headquartered in Toronto, Canada, with a dedicated United States entity to manage its American operations and commercialization efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Induce Biologics USA.